Login / Signup

Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2°P-TIMI 50 trial.

Siddharth M PatelDavid A MorrowStephen K KiddErica L GoodrichBenjamin M SciricaMarc P Bonaca
Published in: Vascular medicine (London, England) (2019)
Keyphrases
  • peripheral artery disease
  • phase iii
  • study protocol
  • middle aged
  • phase ii
  • clinical trial
  • community dwelling
  • open label
  • randomized controlled trial
  • double blind